Vifor Pharma UK Limited: UK Public Sector Contracts Won & Awards

Companies House: Private Limited CompanyMaidenheadSouth East EnglandMain market: Pharmaceutical products

Official UK PPONPTLY-2878-GQMZ

Procedures with an award1618 award records
i

How many tenders this supplier has won.

Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.

Public authorities8named on published awards
i

How many different public bodies have awarded to this supplier.

Buyers named on its awards, with duplicate names merged.

Attributable award value£10mnet · on 2 of 18 award records · single-supplier, no ceilings
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

Last 12 months5awards · 5 in the prior 24 months · last 6 Jul 2026
i

Awards to this supplier in the last 12 months.

Award records dated in the last 12 months, against the two years before.

Contracts ending ≤18 months3end date on 15 of 18 awards · 1 estimated
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

Buyer regions5most often Greater London
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

Where they win
i

In which categories this supplier wins.

Distinct awards by the main category of the lot, or of the procedure when no lot is named. Repeat publications count once.

An award counts once in each class it covers; classes can overlap.

Active awards, plus pending awards whose standstill has ended or was not published.

18 awards (17 for a named lot, 94%, 1 for a whole procedure with no lot named) · top CPV classes, shares of all 18 awards. An award may cover more than one class.

3360 Pharmaceutical products18 awards · 100% · 17 awards naming a lot + 1 whole-procedure awards
Attributable award value
i

How much this supplier has won, by published values.

Sum of award values where it was the only winner, VAT excluded, framework ceilings left out.

Not turnover. Not every award publishes a value.

£10mOn 2 of 18 award records; the five largest make 100%. Largest rows below.
Largest published awards
i

The biggest published awards.

Awards to a single supplier with a published value, largest first, so you can check the totals against the notice.

A repeated framework total can appear here. Open the notice to check.

AuthorityAwardedTermPublished value
Erythropoietin Stimulating Agents & IV IronVelindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)——£9,583,941 †
Proprietary DrugseTenderwales——£667,600 †

Where their buyers are
i

In which regions this supplier wins work.

The region of each buyer it won from: the buyer’s office, placed by the official ONS postcode lookup. Each procedure counts once.

Where the buyer is based, not necessarily where the work was done; the tender page shows the published place of delivery.

ITL1 region of the buyer office · known for 16 of 16 awarded procedures · each procedure counts once

Greater London7 procedures · 44%
Wales (Cymru)3 procedures · 19%
Scotland3 procedures · 19%
North West England2 procedures · 13%
Northern Ireland1 procedures · 6%

Bidding record
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

Procurement Act 2023 award notices name every bidder · 1 notices name this supplier since 21 Jul 2026 · observed bids, not an estimate

Contract lots contested
i

Competitions this supplier is known to have bid in.

Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.

0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i

Frameworks and DPS this supplier got onto.

Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.

1 of 1
Authorities bid for
i

How many public bodies this supplier has bid to.

Buyers on notices that name it as a bidder, win or lose.

1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Which public bodies award work to this supplier.

Authorities named on its published awards, ranked by distinct procedures, duplicate names merged.

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i

What kinds of public bodies award work to this supplier.

Its award records by the authority’s published type, otherwise by its name. One framework can add many records.

  • NHS & health72%(13 awards)
    13 of 18 awards are NHS & health (72%).
  • Central government17%(3 awards)
    3 of 18 awards are Central government (17%).
  • Type not classified11%(2 awards)
    2 of 18 awards are Type not classified (11%).

Share = of the 16 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

Contracts that finish in the next 18 months.

Contracts ending in that window by the published end date or, where only a duration is published, an estimate from signature plus duration (marked). Neither, not counted.

An end date does not confirm a new procurement.

15 of 18 awards carry an end date, 3 estimated from the duration · not a retender forecast

ContractEndsPublished value
NP49425 Generic and Biosimilar Transition Medicines28 Feb 2027£64,103,740
Intravenous (IV) Iron21 Jun 2027 estimated£5,578,980
Denosumab (Osteoporosis) and Ferric Carboxymaltose31 Jul 2027£2,254,091

Recent awards

Latest 18 of 18 award records naming this supplier

Award / procedureAuthorityAwardedPublished value
Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & EastNHS England15 Jun 2026£665,389,588
framework ceiling · 1 of 25 appointed suppliers
Transitional Drugs 7NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)4 Jun 2026£16,804,001
joint award · 10 suppliers
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£2,324,606 †
dynamic market estimate · not attributable revenue
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£64,103,740 †
framework ceiling · 1 of 31 appointed suppliers
Denosumab (Osteoporosis) and Ferric CarboxymaltoseThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£2,254,091 †
framework ceiling · 1 of 11 appointed suppliers
Proprietary DrugseTenderwalesNot published£667,600 †
from the contract notice
Intravenous (IV) IronThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Not published£5,578,980 †
framework ceiling · 1 of 2 appointed suppliers
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche ANHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions on this page are where the work is delivered, not the supplier’s registered address.
  • Contract end dates. Published on 12 of 18 awards, estimated from the published duration on 3 more (marked “estimated”); those feed “Contracts ending”.
  • Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.